Finance

Pure Bioscience reports revenues of $59,442 for the second quarter

Published in AIDS Weekly, April 17th, 2006

Pure Bioscience (PURE) reported revenues for the second quarter of $59,442 from continuing operations, as compared with revenues of $50,964 in the second quarter of the prior year.

The company reported a second quarter loss from continuing operations before taxes of ($919,156), or ($0.05) per share, as compared with a loss of ($771,829), or ($0.04) per share in the same period last year.

Revenues from continuing operations for the 6-month period were $114,611, as compared with revenues of $76,411 in the same period last year. The company reported a loss from continuing operations before taxes of ($1,528,690), or ($0.09) per share, compared with a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2006-04-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry